Oculis Holding AG Ordinary shares (OCS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Oculis Holding AG Ordinary shares (OCS) is down 41.6% since the beginning of the year. At $12 per share, OCS is trading 66.1% below its 52-week high of $34.

Oculis Holding AG Ordinary shares (OCS) has returned -41.56% so far this year and -39.47% over the past 12 months.

Based on dividend-adjusted daily data since Mar 2, 2023, OCS's average daily return is +0.07%, while the average monthly return is +1.77%. At this rate, an investment would double in approximately 3.3 years.

Historically, 58% of months were positive and 43% were negative. The best month was Apr 2023 with a return of +49.8%, while the worst month was Jun 2026 at -48.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 3 months.

On a daily basis, OCS closed higher 47% of trading days. The best single day was Oct 21, 2024 with a return of +18.1%, while the worst single day was Jun 1, 2026 at -36.1%.

Oculis Holding AG Ordinary shares has an annualized alpha of 4.22%, beta of 0.64, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since March 02, 2023.

• This stock participated in 186.87% of S&P 500 Index downside but only 76.25% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.64 may look defensive, but with R2 of 0.03 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

OCS ranks 14 for risk / return — in the bottom 14% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Oculis Holding AG Ordinary shares. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Oculis Holding AG Ordinary shares was 67.20%, occurring on Jun 8, 2026. The portfolio has not yet recovered.

The current Oculis Holding AG Ordinary shares drawdown is 64.26%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Oculis Holding AG Ordinary shares over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Oculis Holding AG Ordinary shares is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.